The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing.
Ontology highlight
ABSTRACT: The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing.
PROVIDER: PRJNA596658 | ENA |
REPOSITORIES: ENA
ACCESS DATA